466 related articles for article (PubMed ID: 18284415)
41. Frequency of 5'IGH deletions in B-cell chronic lymphocytic leukemia.
Quintero-Rivera F; Nooraie F; Rao PN
Cancer Genet Cytogenet; 2009 Apr; 190(1):33-9. PubMed ID: 19264231
[TBL] [Abstract][Full Text] [Related]
42. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
[TBL] [Abstract][Full Text] [Related]
43. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.
Avet-Loiseau H; Facon T; Daviet A; Godon C; Rapp MJ; Harousseau JL; Grosbois B; Bataille R
Cancer Res; 1999 Sep; 59(18):4546-50. PubMed ID: 10493504
[TBL] [Abstract][Full Text] [Related]
44. Complex rearrangements involving der(8)t(8;20) and der(14)t(8;14)t(11;14), CCND1, and duplication of IgH constant region in acute plasmablastic leukemia.
Knutsen T; Vakulchuk A; Mosijczuk AD; Gabrea A; Ried T; Tretyak N
Cancer Genet Cytogenet; 2006 Jan; 164(2):137-41. PubMed ID: 16434317
[TBL] [Abstract][Full Text] [Related]
45. Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China.
Lai YY; Huang XJ; Cai Z; Cao XS; Chen FP; Chen XQ; Chen BA; Fang MY; Feng JF; Fu WL; Guo HY; Hou M; Hou J; Hu Y; Hu XT; Hu XM; Huang LQ; Jin J; Li JY; Li J; Li W; Liang YM; Liu T; Liu QF; Liu YH; Mao P; Ouyang J; Qiu LG; Qiu L; Shao CK; Shi B; Song YP; Sun ZM; Wang QS; Wang C; Wang JM; Wang YS; Wang Z; Wu JB; Wu YX; Xia RX; Xue YQ; Yang BZ; Yang G; Yang ZL; Yu L; Yuan Z; Zhang S; Zhang Y; Zhao HG; Zhao L; Zhou DB; Zou SH; Zhu YF
Chin Med J (Engl); 2012 Aug; 125(15):2663-70. PubMed ID: 22931972
[TBL] [Abstract][Full Text] [Related]
46. Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance.
Schmidt-Wolf IG; Glasmacher A; Hahn-Ast C; Jüttner A; Schnurr T; Cremer F; Moehler T; Goldschmidt H; Busert B; Schubert R; Schwanitz G
Cancer Genet Cytogenet; 2006 May; 167(1):20-5. PubMed ID: 16682281
[TBL] [Abstract][Full Text] [Related]
47. t(14;22)(q32;q11) in non-Hodgkin lymphoma and myeloid leukaemia: molecular cytogenetic investigations.
Aamot HV; Bjørnslett M; Delabie J; Heim S
Br J Haematol; 2005 Sep; 130(6):845-51. PubMed ID: 16156854
[TBL] [Abstract][Full Text] [Related]
48. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
[TBL] [Abstract][Full Text] [Related]
49. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.
Cavazzini F; Hernandez JA; Gozzetti A; Russo Rossi A; De Angeli C; Tiseo R; Bardi A; Tammiso E; Crupi R; Lenoci MP; Forconi F; Lauria F; Marasca R; Maffei R; Torelli G; Gonzalez M; Martin-Jimenez P; Maria Hernandez J; Rigolin GM; Cuneo A
Br J Haematol; 2008 Aug; 142(4):529-37. PubMed ID: 18547320
[TBL] [Abstract][Full Text] [Related]
50. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation.
Avet-Loiseau H; Facon T; Grosbois B; Magrangeas F; Rapp MJ; Harousseau JL; Minvielle S; Bataille R;
Blood; 2002 Mar; 99(6):2185-91. PubMed ID: 11877296
[TBL] [Abstract][Full Text] [Related]
51. 13q14 deletions are not primary events in B-cell chronic lymphocytic leukemia: a study of 100 patients using fluorescence in situ hybridization.
Avet-Loiseau H; Devilder MC; Garand R; Bouyge I; Rapp MJ; Milpied N; Harousseau JL; Moisan JP; Bataille R
Clin Cancer Res; 1996 Oct; 2(10):1673-7. PubMed ID: 9816115
[TBL] [Abstract][Full Text] [Related]
52. Chromosomal imbalances in adult T-cell leukemia revealed by comparative genomic hybridization: gains at 14q32 and 2p16-22 in cell lines.
Ariyama Y; Mori T; Shinomiya T; Sakabe T; Fukuda Y; Kanamaru A; Yamada Y; Isobe M; Seto M; Nakamura Y; Inazawa J
J Hum Genet; 1999; 44(6):357-63. PubMed ID: 10570904
[TBL] [Abstract][Full Text] [Related]
53. CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q.
Liebisch P; Eppinger S; Schöpflin C; Stehle G; Munzert G; Döhner H; Schmid M
Haematologica; 2005 Apr; 90(4):489-93. PubMed ID: 15820944
[TBL] [Abstract][Full Text] [Related]
54. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
[TBL] [Abstract][Full Text] [Related]
55. BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders.
Michaux L; Mecucci C; Stul M; Wlodarska I; Hernandez JM; Meeus P; Michaux JL; Scheiff JM; Noël H; Louwagie A; Criel A; Boogaerts M; Van Orshoven A; Cassiman JJ; Van Den Berghe H
Genes Chromosomes Cancer; 1996 Jan; 15(1):38-47. PubMed ID: 8824724
[TBL] [Abstract][Full Text] [Related]
56. Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis.
Koren-Michowitz M; Hardan I; Berghoff J; Yshoev G; Amariglio N; Rechavi G; Nagler A; Trakhtenbrot L
Cancer Lett; 2007 Oct; 255(2):307-14. PubMed ID: 17590504
[TBL] [Abstract][Full Text] [Related]
57. Identification of 13q deletion, trisomy 1q, and IgH rearrangement as the most frequent chromosomal changes found in Korean patients with multiple myeloma.
Bang SM; Kim YR; Cho HI; Chi HS; Seo EJ; Park CJ; Yoo SJ; Kim HC; Chun HG; Min HC; Oh BR; Kim TY; Lee JH; Lee DS
Cancer Genet Cytogenet; 2006 Jul; 168(2):124-32. PubMed ID: 16843102
[TBL] [Abstract][Full Text] [Related]
58. Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region.
Maravelaki S; Burford A; Wotherspoon A; Joshi R; Matutes E; Catovsky D; Brito-Babapulle V
Cancer Genet Cytogenet; 2004 Oct; 154(1):67-71. PubMed ID: 15381376
[TBL] [Abstract][Full Text] [Related]
59. [Fluorescent in situ hybridization with a panel of probes detects molecular cytogenetic abnormalities in patients with chronic lymphocytic leukemia].
Xu W; Li JY; Li L; Yu H; Shen QD; Fan L; Qiao C; Hong M; Qian SX; Qiu HX
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2537-40. PubMed ID: 19080644
[TBL] [Abstract][Full Text] [Related]
60. [Investigation of the molecular changes in patients with multiple myeloma by fluorescence in situ hybridization].
Yang RF; Li CM; Chen LJ; Qiu HR; Yang H; Liu P; Xu JR; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct; 27(5):567-70. PubMed ID: 20931539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
